Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This clinical trial studies positron emission tomography imaging in using copper Cu 64
TP3805in patients with breast cancer. Diagnostic procedures, such as positron emission
tomography (PET) and positron emission mammography (PEM) scan, using Cu-64-TP3805 may help
doctors find and diagnose breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University